CureDRPLA Global Patient Registry is available!

What is DRPLA?

Dentatorubral-pallidoluysian atrophy, commonly known as DRPLA, is a progressive brain disorder that affects coordination, balance, speech, and causes involuntary movements, emotional problems, and a decline in thinking ability. The average age of onset of DRPLA is 30 years, but this condition can appear anytime from infancy to adulthood. The symptoms and progression vary depending on the age of onset.

What is CureDRPLA?

CureDRPLA is a US based non-profit founded by Paul and Andrea Compton. Paul and Andrea have a son that was diagnosed with DRPLA in August 2018. The mission of CureDRPLA is to connect families, physicians and scientific investigators to further DRPLA research and work towards a treatment for DRPLA. This webpage was created to find others that have this condition and are interested in finding a cure.

CureDRPLA
Global
Patient
Registry

The CureDRPLA Global Patient Registry is a worldwide registry of DRPLA patients.

This registry gathers the demographic and clinical information on DRPLA patients from across the globe.  By collecting information on all DRPLA patients, the CureDRPLA Global Patient Registry will be a powerful resource for research and will enhance opportunities for treatment development.

Patient & Caregiver

Click below to find out what CureDRPLA has done and what we are currently doing to find to a treatment for DRPLA.  You will also find online resources and support organizations for DRPLA as well as YouTube channels specifically focused on DRPLA.

Click below to find out what CureDRPLA has done and what we are currently doing to find a treatment for DRPLA.  You will also find online resources and support organizations for DRPLA as well as YouTube channels specifically focused on DRPLA.

Patient &
Caregiver

Researcher
& Industry

CureDRPLA is investing in a number of projects in hopes of rapidly developing novel therapeutics for DRPLA.  Information on funding opportunities, a list of our preclinical projects as well as other efforts can be found here.

Latest

Watch the recording of the 2025 DRPLA Research Update

We recorded our annual update so you can watch it at your own pace. It includes updates on our organization, N-of-1 trials, DRPLA Natural History and Biomarkers Study, Patient Registry and other relevant news and projects.

25th September is International Ataxia Awareness Day (IAAD)

This year we are raising awareness about DRPLA. Let’s come together to share our 5-Year Progress Report, which includes:✔️ A comprehensive summary of DRPLA✔️ Highlights of research projects funded by CureDRPLA✔️ Updates on efforts to advance treatments for...

Prof Darren Monckton joins CureDRPLA as Scientific Consultant

Darren Monckton is a Professor of Human Genetics at the University of Glasgow and he will be advising CureDRPLA on scientific matters. Prof Monckton brings years of experience in research for conditions like Huntington’s disease and Myotonic Dystrophy. His expertise...

5 years of CureDRPLA

CureDRPLA was incorporated as a non-profit foundation in November 2019 by Paul and Andrea Compton. We are honoring 5 years of CureDRPLA with this impact report. In this report you will find a summary of our achievements to date and our goals for the next 5...

Join us at ICAR – November 12-15

ICAR, largest gathering of ataxia scientists and medical professionals, will take place in London, November 12-15. CureDRPLA team members will be there, along with scientists working on DRPLA who will present their latest research.

DRPLA n-of-1 clinical trial

Take a few minutes to read this announcement about an upcoming n-of-1 clinical trial for an individual with DRPLA based in the US.

Watch our 2023 DRPLA research update

Every year, we like to provide an update on our projects, offering you insight into what we are working on and what is on the horizon. Do not miss out! https://youtu.be/9R5UcB26_FU

Register for DRPLA Research Talk and Q&A, Nov 14

Event tailored for individuals with DRPLA, their families and anyone interested in DRPLA. Make sure to register in advance (it’s free!). Our Research Manager, Dr Silvia Prades, will be providing a comprehensive update on the projects funded by CureDRPLA. Followed by a...

The 2023 CureDRPLA Research Conference is taking place in Boston on October 10-11

We hosted the first-ever CureDRPLA Research Conference in May 2022, with participation from scientists, neurologists, and representatives from pharmaceutical and biotech companies. It was such a huge success that we decided to make it a yearly event and the time has...

Sign up for CureDRPLA newsletter

Be among the first to know and become part of our community. Sign up here.

News

Updates from the DRPLA Centers of Excellence

Updates from the DRPLA Centers of Excellence

CureDRPLA awards DRPLA Centers of Excellence accreditations to those neurologists who have experience in DRPLA care and commit to supporting our work. In addition to providing expert clinical care and identifying the various needs of those diagnosed with DRPLA, this...

read more

Social

1 week ago

Cure DRPLA
The DRPLA scientific community has grown in recent years, reflected in the increasing number of researchers presenting their work at conferences. Read the full article on our website curedrpla.org/en/2026/03/23/presenting-drpla-research-projects-at-conferences/ ... See MoreSee Less
View on Facebook

2 weeks ago

Cure DRPLA
Discover our short guide on genetic testing for DRPLA. Eligibility, costs, and availability vary significantly by country and healthcare system. We recommend starting with your local healthcare provider or genetics clinic to understand your options. You can also reach out to us, and we may be able to direct you to resources tailored to your needs and local regulations. Read the full article on our website curedrpla.org/en/2026/03/16/information-on-genetic-testing/ ... See MoreSee Less
View on Facebook

3 weeks ago

Cure DRPLA
As we shared our latest newsletter, Prof Jeff Carroll our longstanding Scientific Advisor since CureDRPLA was founded has resigned to pursue new opportunities. While we will miss Jeff on our team, we are grateful for the time he spent with us and for the scientific expertise he brought to the role.Jeff was instrumental in setting the direction of CureDRPLA and shaped our strategy for which therapeutic modalities to prioritize. A key milestone driven by Jeff was the development of mouse models of DRPLA to test possible treatments.We thank Jeff for his many contributions and wish him every success in his next chapter. He leaves big shoes to fill; however, we are exploring our options and hope to appoint a replacement soon. ... See MoreSee Less
View on Facebook

1 month ago

Cure DRPLA
Today, February 28, is Rare Disease Day. The primary goal of this campaign is to increase awareness among the general public and decision-makers about rare diseases and their influence on the lives of families living with these conditions. With over 300 million people globally living with a rare disease, we join hands across borders and amidst the 6000+ rare diseases to advocate for equitable access to diagnosis, treatment, care, and social opportunities. Share this post on your social media to raise awareness about rare diseases. ... See MoreSee Less
View on Facebook

CureDRPLA Global Patient Registry

The CureDRPLA Global Patient Registry aims to collect data on up to as many DRPLA patients as possible. Participants will be asked to complete a set of questionnaires after enrollment with email requests for yearly updates. Data collected include participant demographic and contact information, details about diagnosis, functional mobility status, health economics, medical history, and activities of daily living.